We are live on ! Find out more
GHA

GW Henssler & Associates Portfolio holdings

AUM $2.25B
1-Year Est. Return 19.46%
This Fund
S&P 500
This Quarter Est. Return
+3.83%
1 Year Est. Return
+19.46%
3 Year Est. Return
+62.37%
5 Year Est. Return
+80.78%
10 Year Est. Return
+246.91%
AUM
$1.1B
AUM Growth
+$13.3M
Cap. Flow
-$24.2M
Cap. Flow %
-2.19%
Top 10 Hldgs %
27.52%
Holding
243
New
37
Increased
59
Reduced
88
Closed
42

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$16.6M
2
MET icon
MetLife
MET
+$12.3M
3
TROW icon
T. Rowe Price
TROW
+$11M
4
SCHW
Charles Schwab
SCHW
+$10.8M
5
BLK icon
Blackrock
BLK
+$7.3M

Sector Composition

Rank Sector Weight
1 Healthcare 12.28%
2 Consumer Staples 11.92%
3 Technology 10.82%
4 Financials 9.16%
5 Energy 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LIN icon
51
Linde
LIN
$226B
$9.77M 0.88%
48,663
-403
-0.8% -$75.4K
ORCL icon
52
Oracle
ORCL
$423B
$9.61M 0.87%
168,767
-5,577
-3% -$302K
XLB icon
53
State Street Materials Select Sector SPDR ETF
XLB
$8.66B
$9.43M 0.85%
322,392
-1,374
-0.4% -$38.8K
SLB icon
54
SLB Ltd
SLB
$75B
$9.3M 0.84%
234,125
+7,098
+3% +$286K
REGN icon
55
Regeneron Pharmaceuticals
REGN
$80.8B
$8.68M 0.79%
+27,739
New +$9.23M
T icon
56
AT&T
T
$163B
$8.46M 0.77%
334,400
+314,169
+1,553% +$7.54M
GIS icon
57
General Mills
GIS
$19.7B
$7.6M 0.69%
144,768
+2,487
+2% +$129K
TMO icon
58
Thermo Fisher Scientific
TMO
$220B
$7.48M 0.68%
25,471
-542
-2% -$149K
DRI icon
59
Darden Restaurants
DRI
$24.4B
$6.93M 0.63%
56,896
-1,456
-2% -$173K
UL icon
60
Unilever
UL
$136B
$6.75M 0.61%
96,852
+2,892
+3% +$196K
MD icon
61
Pediatrix Medical
MD
$2.2B
$6.44M 0.58%
255,285
-18,453
-7% -$496K
SNY icon
62
Sanofi
SNY
$104B
$6.34M 0.57%
146,623
+2,049
+1% +$87.1K
BTI icon
63
British American Tobacco
BTI
$128B
$6.26M 0.57%
179,526
+9,768
+6% +$370K
VZ icon
64
Verizon
VZ
$196B
$5.79M 0.52%
101,381
+544
+0.5% +$31.3K
CAH icon
65
Cardinal Health
CAH
$55.4B
$5.72M 0.52%
121,398
-6,431
-5% -$297K
WDC icon
66
Western Digital
WDC
$150B
$5.17M 0.47%
+143,761
New +$4.93M
HD icon
67
Home Depot
HD
$355B
$4.78M 0.43%
22,979
-701
-3% -$140K
PRGO icon
68
Perrigo
PRGO
$1.78B
$4.78M 0.43%
100,332
+6,436
+7% +$307K
SCHX icon
69
Schwab US Large- Cap ETF
SCHX
$74.6B
$3.92M 0.36%
335,454
+21,594
+7% +$248K
ITW icon
70
Illinois Tool Works
ITW
$84.5B
$3.9M 0.35%
25,839
-83
-0.3% -$12.5K
KO icon
71
Coca-Cola
KO
$375B
$3.65M 0.33%
71,739
+11,377
+19% +$558K
GPC icon
72
Genuine Parts
GPC
$18.7B
$3.19M 0.29%
30,822
-13
-0% -$1.35K
PSA icon
73
Public Storage
PSA
$61.3B
$3.17M 0.29%
13,290
+478
+4% +$110K
BDX icon
74
Becton Dickinson
BDX
$48.2B
$2.7M 0.24%
10,983
-595
-5% -$138K
ETN icon
75
Eaton
ETN
$174B
$2.67M 0.24%
32,035
+1,295
+4% +$105K

Similar funds

GW Henssler & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, GW Henssler & Associates held 243 positions worth $1.1B, up 1.2% from $1.09B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

GW Henssler & Associates's Q2 2019 filing shows 37 new, 59 increased, 88 reduced and 42 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 27,739 shares worth $8.68M. The largest sale was Celgene Corp, an estimated $16.6M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 13% a quarter earlier, followed by Consumer Staples and Technology.

  • GW Henssler & Associates's largest Q2 2019 buy was Regeneron Pharmaceuticals: 27,739 shares worth $8.68M.
  • GW Henssler & Associates added most to State Street Utilities Select Sector SPDR ETF in Q2 2019, an estimated $11.5M increase.
  • GW Henssler & Associates's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $16.6M.
  • GW Henssler & Associates fully exited NIC Inc in Q2 2019, selling an estimated $1.2M.
  • GW Henssler & Associates's ten largest holdings make up 28% of its $1.1B portfolio in Q2 2019.
  • GW Henssler & Associates opened 37 new positions and closed 42 in Q2 2019.
  • GW Henssler & Associates's portfolio value rose 1.2% quarter-over-quarter to $1.1B.

Based on GW Henssler & Associates's 13F filing for Q2 2019, filed 5 Aug 2019.